ETC
AMPH icon

Exchange Traded Concepts’s Amphastar Pharmaceuticals AMPH Stock Holding History

Exchange Traded Concepts’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
87,054
+4,638
+6% +$93.6K 0.01% 753
2026
Q1 		$1.61M Buy
82,416
+72,998
+775% +$1.79M 0.01% 657
2025
Q4 		$252K Sell
9,418
-567
-6% -$14.6K ﹤0.01% 1152
2025
Q3 		$266K Buy
9,985
+154
+2% +$3.98K ﹤0.01% 1134
2025
Q2 		$226K Buy
9,831
+965
+11% +$23.9K ﹤0.01% 1128
2025
Q1 		$257K Buy
+8,866
New +$283K ﹤0.01% 886
2024
Q1 		– Sell
-21,440
Closed -$1.33M – 1245
2023
Q4 		$1.33M Buy
21,440
+169
+0.8% +$8.88K 0.04% 339
2023
Q3 		$978K Sell
21,271
-24,822
-54% -$1.35M 0.03% 394
2023
Q2 		$2.65M Sell
46,093
-490
-1% -$21.7K 0.07% 232
2023
Q1 		$1.75M Buy
46,583
+9,431
+25% +$309K 0.05% 229
2022
Q4 		$1.04M Buy
37,152
+1,135
+3% +$33K 0.03% 305
2022
Q3 		$1.01M Sell
36,017
-18,276
-34% -$597K 0.03% 267
2022
Q2 		$1.89M Buy
54,293
+1,612
+3% +$57.5K 0.05% 168
2022
Q1 		$1.89M Buy
52,681
+27,698
+111% +$785K 0.04% 234
2021
Q4 		$582K Buy
+24,983
New +$511K 0.01% 563
2021
Q3 		– Sell
-57,851
Closed -$1.17M – 1101
2021
Q2 		$1.17M Buy
57,851
+5,517
+11% +$104K 0.04% 289
2021
Q1 		$959K Buy
52,334
+35,769
+216% +$665K 0.04% 300
2020
Q4 		$333K Buy
16,565
+756
+5% +$14.7K 0.02% 520
2020
Q3 		$296K Buy
+15,809
New +$318K 0.02% 473

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Exchange Traded Concepts's AMPH Position: Q2 2026 in Review

Exchange Traded Concepts increased its Amphastar Pharmaceuticals (AMPH) stake by 5.6% in Q2 2026, buying an estimated $93.6K and bringing the position to 87,054 shares worth $1.76M. The position accounts for 0.01% of the portfolio, ranked #753.

Exchange Traded Concepts first reported a position in AMPH in Q3 2020 and has held it in 19 quarters since. The position peaked at $2.65M in Q2 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Exchange Traded Concepts held 87,054 shares of Amphastar Pharmaceuticals worth $1.76M as of Q2 2026.
  • Exchange Traded Concepts bought 4,638 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $93.6K.
  • Amphastar Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #753 holding.
  • Exchange Traded Concepts first reported a position in Amphastar Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • Exchange Traded Concepts's Amphastar Pharmaceuticals position peaked at $2.65M in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.